CoChat

Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study

Eliasson, Björn, Liakopoulos, Vasileios, Franzén, Stefan, Näslund, Ingmar, Svensson, Ann-Marie, Ottosson, Johan, Gudbjörnsdottir, Soffia · 2015 · The Lancet Diabetes & Endocrinology

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Background In patients with diabetes and obesity specifically, no studies have examined mortality after bariatric surgery. We did a nationwide study in Sweden to examine risks of cardiovascular disease and mortality in patients with obesity and diabetes who had undergone bariatric surgery (Roux-en-Y gastric bypass [RYGB]).Methods In this nationwide, matched, observational cohort study, we merged data for patients who had undergone RYGB registered in the Scandinavian Obesity Surgery Registry with other national databases, and identified matched controls (on the basis of sex, age, BMI, and calendar time [year]) who had not undergone bariatric surgery from the National Diabetes Registry. We assessed risks of cardiovascular disease and death using a Cox proportional-hazards regression model and other methods to examine the treatment effect while accounting for residual confounding. Primary outcomes were total mortality, cardiovascular death, and fatal or non-fatal myocardial infarction.Findings Between Jan 1, 2007, and Dec 31, 2014, we obtained data for 6132 patients who had undergone RYGB and 6132 control patients who had not. Median follow-up was 3·5 years (IQR 2·1-4·7). We noted a 58% relative risk reduction (hazard ratio [HR] 0·42, 95% CI 0·30-0·57; p<0·0001) in overall mortality in the RYGB group compared with the controls. The risk of fatal or non-fatal myocardial infarction was 49% lower (HR 0·51, 0·29-0·91; p=0·021) and that of cardiovascular death was 59% lower (0·41, 0·19-0·90; p=0·026) in the RYGB group than in the control group. 5 year absolute risks of death were 1·8% (95% CI 1·5-2·2) in the RYGB group and 5·8% (5·0-6·8) in the control group.Interpretation Our findings provide support for the benefits of RYGB surgery for patients with obesity and type 2 diabetes. The causes of these beneficial effects may be the weight reduction per se, changes in physiology and metabolism, improved care and treatment, improvements in lifestyle and risk factors, or combinations of these factors.Funding Swedish Association of Local Authorities and Regions and Region Västra Götaland.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(15)00334-4

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 1

  1. 2014, Obesity (Silver Spring), 22, S5

Cited by

See all 167

Metadata

Authors
Eliasson, B., Liakopoulos, V., Franzén, S., Näslund, I., Svensson, A.-M., Ottosson, J., & Gudbjörnsdottir, S.
Affiliations
  • Sahlgrenska University Hospital (SE)
  • University of Gothenburg (SE)
  • Örebro University (SE)
Corresponding author
Eliasson, Björn
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2015-11
Volume
3
Issue
11
Pages
847-854
ISSN
2213-8587 (ISSN-L)
OpenAlex
W1850297445
Cited by
167
References
28
Citations by year
2026: 5 · 2025: 6 · 2024: 7 · 2023: 19 · 2022: 15 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 14 · 2017: 16 · 2016: 25 · 2015: 2
FWCI
19.13
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Västra Götalandsregionen
  • Sveriges Kommuner och Landsting
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac, Anesthesia and Surgical Outcomes
Keywords
bariatric surgery, Roux-en-Y gastric bypass, type 2 diabetes, obesity, cardiovascular disease, mortality, myocardial infarction, cardiovascular mortality, weight loss, diabetes remission, matched cohort, residual confounding, treatment effect estimation, absolute risk reduction
MeSH terms
Adolescent, Adult, Cardiovascular Diseases, Child, Child, Preschool, Diabetes Mellitus, Type 2, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Obesity, Risk Factors, Sweden, Cohort Studies, Gastric Bypass, Proportional Hazards Models, Treatment Outcome, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. https://app.cochat.ai/papers/10.1016/s2213-8587(15)00334-4
The paper
Eliasson, B., Liakopoulos, V., Franzén, S., Näslund, I., Svensson, A.-M., Ottosson, J., & Gudbjörnsdottir, S. (2015). Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(15)00334-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.